Enalapril compositions

US8778366B2 · kind B2 · utility

Assignees

• University of Kansas · US
• SILVERGATE PHARMACEUTICALS, INC. · US

Inventors

• Lian G. Rajewski · Lawrence, US
• Roger A. Rajewski · Lawrence, US
• John L. Haslam · Lawrence, US
• Kathleen Heppert · Lawrence, US
• Michael C. Beckloff · Leawood, US
• Frank Segrave · Dublin, US
• Robert Mauro · Miller Place, US
• Peter Colabuono · Las Vegas, US

Key dates

• Filing date: Jun 10, 2013
• Grant date: Jul 15, 2014
• Expiry date: Jun 10, 2033

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P9/12
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Provided herein are stable enalapril powder compositions for oral liquid formulation. Also provided herein are methods of using enalapril oral liquid formulations for the treatment of certain diseases including hypertension, heart failure and asymptomatic left ventricular dysfunction.